Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sony Tuteja

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Pharmacogenomics|August 9, 2019
Early adoption of pharmacogenetic testing for veterans prescribed psychotropic medicationsLeland E Hull, Catherine Chanfreau-Coffinier, Sony Tuteja, et al.
Journal of Lipid Research|January 26, 2017
Measuring niacin-associated skin toxicity (NASTy) stigmata along with symptoms to aid development of niacin mimeticsRichard L Dunbar, Harsh Goel, Sony Tuteja, et al.
Pain|March 23, 2022
Drug-drug-gene interaction risk among opioid users in the U.S. Department of Veterans AffairsCatherine Chanfreau-Coffinier, Sony Tuteja, Leland E Hull, et al.
Clinical and Translational Science|January 7, 2026
Consent, Concern, and Capacity: Factors Associated With Attitudes Toward Pharmacogenetic Testing Among Patients With Gastrointestinal CancerArravinth Anantharajah, Raza Chaudhry, Victoria A Wittner, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 13, 2024
PGxQA: A Resource for Evaluating LLM Performance for Pharmacogenomic QA TasksKarl Keat, Rasika Venkatesh, Yidi Huang, et al.
Clinical Pharmacology and Therapeutics|November 9, 2022
How to Run the Pharmacogenomics Clinical Annotation Tool (PharmCAT)Binglan Li, Katrin Sangkuhl, Karl Keat, et al.
Journal of Translational Medicine|November 29, 2022
Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank populationShefali S Verma, Karl Keat, Binglan Li, et al.
Circulation|June 20, 2024
<i>CYP2C19</i> Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart AssociationNaveen L Pereira, Sharon Cresci, Dominick J Angiolillo, et al.
JAMA Network Open|June 8, 2019
Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy UsersCatherine Chanfreau-Coffinier, Leland E Hull, Julie A Lynch, et al.
Gut|October 19, 2021
Proton-pump inhibitor use is not associated with severe COVID-19-related outcomes: a propensity score-weighted analysis of a national veteran cohortShailja Shah, Alese Halvorson, Brandon McBay, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Pharmacogenomics|August 9, 2019
Early adoption of pharmacogenetic testing for veterans prescribed psychotropic medicationsLeland E Hull, Catherine Chanfreau-Coffinier, Sony Tuteja, et al.
Journal of Lipid Research|January 26, 2017
Measuring niacin-associated skin toxicity (NASTy) stigmata along with symptoms to aid development of niacin mimeticsRichard L Dunbar, Harsh Goel, Sony Tuteja, et al.
Pain|March 23, 2022
Drug-drug-gene interaction risk among opioid users in the U.S. Department of Veterans AffairsCatherine Chanfreau-Coffinier, Sony Tuteja, Leland E Hull, et al.
Clinical and Translational Science|January 7, 2026
Consent, Concern, and Capacity: Factors Associated With Attitudes Toward Pharmacogenetic Testing Among Patients With Gastrointestinal CancerArravinth Anantharajah, Raza Chaudhry, Victoria A Wittner, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 13, 2024
PGxQA: A Resource for Evaluating LLM Performance for Pharmacogenomic QA TasksKarl Keat, Rasika Venkatesh, Yidi Huang, et al.
Clinical Pharmacology and Therapeutics|November 9, 2022
How to Run the Pharmacogenomics Clinical Annotation Tool (PharmCAT)Binglan Li, Katrin Sangkuhl, Karl Keat, et al.
Journal of Translational Medicine|November 29, 2022
Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank populationShefali S Verma, Karl Keat, Binglan Li, et al.
Circulation|June 20, 2024
<i>CYP2C19</i> Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart AssociationNaveen L Pereira, Sharon Cresci, Dominick J Angiolillo, et al.
JAMA Network Open|June 8, 2019
Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy UsersCatherine Chanfreau-Coffinier, Leland E Hull, Julie A Lynch, et al.
Gut|October 19, 2021
Proton-pump inhibitor use is not associated with severe COVID-19-related outcomes: a propensity score-weighted analysis of a national veteran cohortShailja Shah, Alese Halvorson, Brandon McBay, et al.
Pageof 9